Potential and Limitations of Cross-Protective Vaccine against Malaria by Blood-Stage Naturally Attenuated Parasite
Open Access
Abstract
Human malaria vaccine trials have revealed vaccine efficacy but improvement is still needed. In this study, we aimed to re-evaluate vaccination with blood-stage naturally attenuated parasites, as a whole-organism vaccine model against cross-strain and cross-species malaria, to establish a better vaccination strategy. C57BL/6 mice controlled blood-stage Plasmodium yoelii 17XNL (PyNL) within 1 month of infection, while mice with a variety of immunodeficiencies demonstrated different susceptibilities to PyNL, including succumbing to hyperparasitemia. However, after recovery, survivors had complete protection against a challenge with the lethal strain PyL. Unlike cross-strain protection, PyNL-recovered mice failed to induce sterile immunity against Plasmodium berghei ANKA, although prolonged survival was observed in some vaccinated mice. Splenomegaly is a typical characteristic of malaria; the splenic structure became reorganized to prioritize extra-medullary hematopoiesis and to eliminate parasites. We also found that the peritoneal lymph node was enlarged, containing activated/memory phenotype cells that did not confer protection against PyL challenge. Hemozoins remained in the spleen several months after PyNL infection. Generation of an attenuated human blood-stage parasite expressing proteins from multiple species of malaria would greatly improve anti-malaria vaccination.Keywords
Funding Information
- Japan Society for the Promotion of Science (24790399, 26860276, 18H06139)
This publication has 55 references indexed in Scilit:
- Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36PLOS ONE, 2013
- CD8+ T cell activation by murine erythroblasts infected with malaria parasitesScientific Reports, 2013
- Skin‐draining lymph node priming is sufficient to induce sterile immunity against pre‐erythrocytic malariaEMBO Molecular Medicine, 2012
- The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparumNature Genetics, 2012
- In Vivo Hemozoin Kinetics after Clearance of Plasmodium berghei Infection in MiceMalaria Research and Treatment, 2012
- Superior Antimalarial Immunity after Vaccination with Late Liver Stage-Arresting Genetically Attenuated ParasitesCell Host & Microbe, 2011
- Artemether and Artesunate Show the Highest Efficacies in Rescuing Mice with Late-Stage Cerebral Malaria and Rapidly Decrease Leukocyte Accumulation in the BrainAntimicrobial Agents and Chemotherapy, 2011
- Comparative genomics of the neglected human malaria parasite Plasmodium vivaxNature, 2008
- The role of the spleen and immunization against malariaTrends in Parasitology, 2005
- MHC Class I Expression in Mice Lacking the Proteasome Subunit LMP-7Science, 1994